Figure 2 | Scientific Reports

Figure 2

From: Atractylenolide-I Sensitizes Human Ovarian Cancer Cells to Paclitaxel by Blocking Activation of TLR4/MyD88-dependent Pathway

Figure 2

Expression of VEGF and survivin and levels of soluble IL-6 and VEGF.

(A1–A2). The mRNA expression of VEGF and survivin induced by LPS, paclitaxel and AO-1 in SKOV3 cells and A2780 cells, respectively (n = 3); (B1–B2). The protein expression of VEGF and survivin induced by LPS, paclitaxel and AO-1 in SKOV3 cells and A2780 cells, respectively (n = 3); (C1–C2). Levels of soluble IL-6 and VEGF, induced by combination of paclitaxel with AO-1 in SKOV3 cells and A2780 cells, respectively (n = 3). * P < 0.05, compared to Control.

Back to article page